DrugBank

MARCH 22, 2024

Research is emerging at a never before seen rate, and it is causing challenges for researchers and scientists to not only stay on top of the latest publications, but to validate conflicting information. They also have a reputation of containing hidden inaccuracies and out-of-date information.

Licensing 73

Licensing Licensing Research Clinical Trials 73

Conversations in Drug Development Trends

FEBRUARY 21, 2024

The on-site cGMP Phase 1 pharmacy must have radiolabel drug preparation experience A clinical pharmacology unit (CPU) must be licensed and experienced in handling radioactive investigational drugs in order to complete your AME study.

Clinical Trials 80

Clinical Trials Pharmacy Clinical Pharmacology FDA 80

Codon

JANUARY 21, 2024

It introduced concepts like informed consent and risk/benefit analysis for clinical studies. We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. There have been deaths in phase 1 medical and drug research among healthy participants.

Vaccine 120

Vaccine Trials Disease Treatment 120

The Pharma Data

JANUARY 26, 2021

Food and Drug Administration (FDA) for the treatment of mild to moderate COVID-19 in high-risk patients, and it has also been granted authorizations in several additional countries. For more information about the use of bamlanivimab in the U.S., The webcast information is available here.

Hospitals 52

Hospitals Treatment Trials Long-Term Care Facilities 52

Drug Target Review

FEBRUARY 11, 2025

New era in drug research: data access and NGS The 1990s and 2000s marked a turning point in the drug development landscape, facilitated by a combination of cultural and technological factors that enabled regulatory changes, technological innovations and methodological advances.

Drug Development 59

Drug Development Bioinformatics Small Molecule Drugs 59